Share chart Kodiak Sciences Inc.
Extended chart
Simple chart
About Kodiak Sciences Inc.
Kodiak Sciences Inc., биофармацевтическая компания, работающая на клинической стадии, предлагает новые терапевтические препараты для лечения заболеваний сетчатки. Ведущим кандидатом на продукт компании является KSI-301, биологический агент фактора роста эндотелия сосудов (VEGF), который находится в фазе 1b клинического исследования для лечения влажной возрастной дегенерации желтого пятна (AMD) и диабетической ретинопатии. more detailsMain settings
IPO date | 2018-10-04 |
---|---|
ISIN | US50015M1099 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | link |
Цена ао | 3.44 |
Change price per day: | 0% (3.44) |
---|---|
Change price per week: | -7.28% (3.71) |
Change price per month: | -17.9% (4.19) |
Change price per 3 month: | -18.68% (4.23) |
Change price per half year: | -47.56% (6.56) |
Change price per year: | +12.05% (3.07) |
Change price per 3 year: | -61.9% (9.03) |
Change price per 5 year: | -94.68% (64.61) |
Change price per year to date: | -65.15% (9.87) |
Grade
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Insider trading
Main owners
Institutions | Volume | Share, % |
---|---|---|
Baker Brothers Advisors, LLC | 17 310 490 | 32.97 |
Blackrock Inc. | 4 032 822 | 7.68 |
Acadian Asset Management. LLC | 1 908 302 | 3.63 |
Newtyn Management, LLC | 1 771 241 | 3.37 |
Vanguard Group Inc | 1 643 470 | 3.13 |
Shaw D.E. & Co., Inc. | 1 208 973 | 2.3 |
ICONIQ Capital, LLC | 1 016 864 | 1.94 |
SILVERARC CAPITAL MANAGEMENT, LLC | 1 000 000 | 1.9 |
Jacobs Levy Equity Management, Inc. | 723 675 | 1.38 |
State Street Corporation | 720 435 | 1.37 |
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
---|---|---|---|
Ms. Almas Qudrat M.Sc. | Chief Quality Officer | N/A | |
Dr. Victor Perlroth M.D. | Co-Founder, Chairman, CEO & President | 1.08M | 1973 (52 years) |
Dr. Stephen Raillard Ph.D. | Senior Vice President of Chemical Development & Manufacturing | N/A | |
Dr. J. Pablo Velazquez-Martin M.D. | Chief Medical Officer | N/A | |
Mr. John A. Borgeson CPA, M.B.A. | Executive VP, CFO & Secretary | 667.52k | 1963 (62 years) |
Dr. Dolly S. Chang M.D., M.P.H., Ph.D. | Chief Scientific Officer | ||
Dr. Hong Liang Ph.D. | Senior Vice President of Development | 1972 (53 years) | |
Ms. Tracy Chien | VP & Corporate Controller |
About company
Address: United States, Palo Alto, 1200 Page Mill Road - Open in google maps, Open in yandex maps
Website: http://kodiak.com
Website: http://kodiak.com